Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
2003 1
2005 1
2009 1
2010 1
2014 2
2016 3
2017 2
2018 5
2019 7
2020 10
2021 15
2022 6
2023 5
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry. Díaz-González Á, et al. Hepatology. 2023 Apr 1;77(4):1095-1105. doi: 10.1097/HEP.0000000000000018. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626622 Free article.
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
Hirschfield GM, Bowlus CL, Mayo MJ, Kremer AE, Vierling JM, Kowdley KV, Levy C, Villamil A, Ladrón de Guevara Cetina AL, Janczewska E, Zigmond E, Jeong SH, Yilmaz Y, Kallis Y, Corpechot C, Buggisch P, Invernizzi P, Londoño Hurtado MC, Bergheanu S, Yang K, Choi YJ, Crittenden DB, McWherter CA; RESPONSE Study Group. Hirschfield GM, et al. N Engl J Med. 2024 Feb 29;390(9):783-794. doi: 10.1056/NEJMoa2312100. Epub 2024 Feb 21. N Engl J Med. 2024. PMID: 38381664 Clinical Trial.
Surveillance for hepatocellular carcinoma.
Díaz-González Á, Forner A. Díaz-González Á, et al. Best Pract Res Clin Gastroenterol. 2016 Dec;30(6):1001-1010. doi: 10.1016/j.bpg.2016.10.006. Epub 2016 Oct 21. Best Pract Res Clin Gastroenterol. 2016. PMID: 27938779 Review.
Immune-mediated hepatitis: Basic concepts and treatment.
Velarde-Ruiz Velasco JA, Tapia Calderón DK, Cerpa-Cruz S, Velarde-Chávez JA, Uribe Martínez JF, García Jiménez ES, Aldana Ledesma JM, Díaz-González Á, Crespo J. Velarde-Ruiz Velasco JA, et al. Among authors: diaz gonzalez a. Rev Gastroenterol Mex (Engl Ed). 2024 Jan-Mar;89(1):106-120. doi: 10.1016/j.rgmxen.2023.12.001. Epub 2024 Mar 13. Rev Gastroenterol Mex (Engl Ed). 2024. PMID: 38485561 Free article. Review.
Treatment of Hepatocellular Carcinoma.
Díaz-González Á, Reig M, Bruix J. Díaz-González Á, et al. Dig Dis. 2016;34(5):597-602. doi: 10.1159/000445275. Epub 2016 Jun 22. Dig Dis. 2016. PMID: 27332893 Review.
Controversies in the management of hepatocellular carcinoma.
Forner A, Da Fonseca LG, Díaz-González Á, Sanduzzi-Zamparelli M, Reig M, Bruix J. Forner A, et al. Among authors: diaz gonzalez a. JHEP Rep. 2019 Mar 18;1(1):17-29. doi: 10.1016/j.jhepr.2019.02.003. eCollection 2019 May. JHEP Rep. 2019. PMID: 32039350 Free PMC article. Review.
New Systemic Treatments in Advanced Hepatocellular Carcinoma.
Sanduzzi-Zamparelli M, Díaz-Gonzalez Á, Reig M. Sanduzzi-Zamparelli M, et al. Among authors: diaz gonzalez a. Liver Transpl. 2019 Feb;25(2):311-322. doi: 10.1002/lt.25354. Liver Transpl. 2019. PMID: 30317696 Review.
Biopsy for hepatocellular carcinoma: only occasionally.
Crespo J, Díaz González Á. Crespo J, et al. Among authors: diaz gonzalez a. Rev Esp Enferm Dig. 2020 Aug;112(8):666-667. doi: 10.17235/reed.2020.6935/2020. Rev Esp Enferm Dig. 2020. PMID: 32686436 Free article.
60 results